Omentin-1 vs Follitropin alfa
Head-to-head comparison of Omentin-1 (Omentin-1 (Intelectin-1, ITLN1)) and Follitropin alfa (Recombinant Human Follicle-Stimulating Hormone Alfa) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Omentin-1 | Follitropin alfa |
|---|---|---|
| Category | Diabetes & Metabolic | Sexual Health |
| Full Name | Omentin-1 (Intelectin-1, ITLN1) | Recombinant Human Follicle-Stimulating Hormone Alfa |
| Molecular Weight | ~35 kDa | 30,000 Da |
| Half-Life | hours | ~24 hours |
| Amino Acids | 313 | N/A |
| Typical Dose | No approved human dose; research use only | 75-150 IU per dose |
| Route | IV|SC | Subcutaneous/Intramuscular |
| Purity | ≥98% | ≥98% |
| Studies Count | 82 | 850 |
| Research Status | Pre-clinical | Clinical |
Omentin-1 Benefits
- ✓insulin sensitivity
- ✓glucose uptake
- ✓lipid handling
Follitropin alfa Benefits
- ✓supports spermatogenesis
- ✓improves Sertoli cell signaling
- ✓may enhance sperm parameters
- ✓complements LH-driven testosterone support
Omentin-1 Dosing
not established|not established
Follitropin alfa Dosing
75-150 IU SC/IM 2-3x weekly|adjust based on FSH and semen analysis|often combined with hCG in men
Omentin-1 Side Effects
- ⚠unknown
- ⚠immunogenicity risk
Follitropin alfa Side Effects
- ⚠injection-site reactions
- ⚠headache
- ⚠bloating
Research Overview
Omentin-1
Lower omentin-1 levels are often associated with obesity, insulin resistance, and metabolic syndrome. Research continues on its use as a biomarker and as a mechanistic lead for AMPK-linked metabolic interventions.
Follitropin alfa
Clinical literature supports follitropin alfa for male infertility, especially when combined with LH activity to optimize testicular output. Its role is strongest in hypogonadotropic hypogonadism and assisted reproduction protocols.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.